Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride

BACKGROUND: Sapropterin dihydrochloride effectively lowers plasma phenylalanine (Phe) for at least a third of phenylketonuria (PKU) patients, with potential for increased dietary Phe tolerance and decreased medical food requirement. OBJECTIVE: To investigate long-term quality of life (QOL) in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Douglas, Teresa D, Ramakrishnan, Usha, Kable, Julie A, Singh, Rani H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880979/
https://www.ncbi.nlm.nih.gov/pubmed/24373161
http://dx.doi.org/10.1186/1477-7525-11-218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880979/
https://www.ncbi.nlm.nih.gov/pubmed/24373161
http://dx.doi.org/10.1186/1477-7525-11-218

Ejemplares similares